Alunbrig Tablet, Film Coated
Product Images NDC 63020-180

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Alunbrig (NDC 63020-180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Alunbrig 01)

Chemical structure of brigatinib, the active ingredient in Alunbrig. The structure depicts the molecular arrangement of atoms, including nitrogen, chlorine, oxygen, phosphorus, and carbon atoms, in a detailed chemical diagram.*

FDA Label Image

Principal Display Panel (30 mg Tablet Bottle Label)

Kaplan-Meier survival curves showing progression-free survival (%) over time in months for brigatinib compared to crizotinib. The chart includes the number of patients at risk at various time points for both treatments. Brigatinib curve shows higher progression-free survival than crizotinib across the observed period up to 36 months.*

FDA Label Image

Principal Display Panel (90 mg Tablet Bottle Label)

Packaging label for Alunbrig 30 mg film-coated tablets containing brigatinib. The label states storage instructions for controlled room temperature and includes a note to keep away from children. It indicates the package contains 30 tablets, is distributed by Takeda Pharmaceuticals America, Inc., and has the product origin listed as the UK.*

FDA Label Image

Principal Display Panel (180 mg Tablet Bottle Label)

Packaging label for Alunbrig tablets containing 90 mg of brigatinib. The label shows the product name, strength, and dosage form as film-coated oral tablets. It includes storage instructions, a barcode, and the labeler information as Takeda Pharmaceuticals America, Inc. The package contains 30 tablets for prescription use only.*

FDA Label Image

Principal Display Panel (Kit Carton)

Packaging label for Alunbrig 180 mg tablets, a film-coated oral tablet containing brigatinib. The label indicates a 30 tablets count and is distributed by Takeda Pharmaceuticals America, Inc. The label includes dosage storage instructions and emphasizes prescription use only.*

FDA Label Image

Alunbrig 06

Packaging label for Alunbrig (brigatinib) tablets oral initiation pack by Takeda Pharmaceuticals America, Inc. The label shows two bottle doses: a 90 mg initial dose bottle with 7 tablets and a 180 mg regular dose bottle with 23 tablets. It includes dosage instructions indicating one 90 mg tablet daily for the first 7 days, followed by one 180 mg tablet daily from days 8 to 30. The storage instructions specify controlled room temperature conditions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.